Additionally, we examined the effects of SR4 on hepatic and adipose AMPK activation, adipose hypertrophy, liver steatosis, as well as analyzed the effects of the compound on various genes associated with hepatic lipid and glucose metabolism. Here, PRKAA1 is linked to fatty liver disease.